Clinical trial NCT03802799
Status: Active, not recruitingPhase 2/3Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
- Record number
- NCT03802799
- Status
- Active, not recruiting
- Type and phase
- Clinical trial, phase 2/3
- Participants
- 476 (actual)
- Condition (as registered)
- Fragile X Syndrome
- Countries
- Australia, New Zealand, United Kingdom, United States
- Topic in the guide
- Outside the topics in the guide
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: November 9, 2018
- End of data collection for primary results: June 30, 2026
- Trial completion: June 30, 2026
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Active, not recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Thinking of taking part? Which specialist to see